A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

Scientists are encouraged by findings that jab can eliminate tumour in patients with stage three or four kidney cancer ...

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...

His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...

Tim Andrews, 66, is living with a pig kidney following a pioneering transplant at Massachusetts General Hospital. This ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

For the past two decades, scientists have been manipulating genes to grow human cells where you wouldn’t quite expect them.